<!DOCTYPE html>
<html lang="en">

<head>
    <!-- Required meta tags -->
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">
    <!-- Bootstrap CSS -->
    <link rel="stylesheet" href="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/css/bootstrap.min.css"
        integrity="sha384-ggOyR0iXCbMQv3Xipma34MD+dH/1fQ784/j6cY/iJTQUOhcWr7x9JvoRxT2MZw1T" crossorigin="anonymous">
    <!-- Navbar CSS -->
    <link rel="stylesheet" href="../navbar/navbar.css">
    <!-- Description page CSS -->
    <link rel="stylesheet" href="description.css">
    <!-- Carousel CSS -->
    <link rel="stylesheet" href="carousel.css">
    <!-- Font awesome -->
    <link rel="stylesheet" href="https://use.fontawesome.com/releases/v5.8.1/css/all.css"
        integrity="sha384-50oBUHEmvpQ+1lW4y57PTFmhCaXp0ML5d60M1M7uH2+nqUivzIebhndOJK28anvf" crossorigin="anonymous">
    <!-- Google fonts -->
    <link href="https://fonts.googleapis.com/css?family=Montserrat:400,700" rel="stylesheet" type="text/css">
    <link href='https://fonts.googleapis.com/css?family=Kaushan+Script' rel='stylesheet' type='text/css'>
    <link href='https://fonts.googleapis.com/css?family=Droid+Serif:400,700,400italic,700italic' rel='stylesheet'
        type='text/css'>
    <link href='https://fonts.googleapis.com/css?family=Roboto+Slab:400,100,300,700' rel='stylesheet' type='text/css'>

    <title>Description</title>
</head>

<body>

    <!-- Navigation -->
    <nav class="navbar navbar-expand-lg navbar-dark fixed-top" id="mainNav">
        <div class="container">
            <a class="navbar-brand js-scroll-trigger" href="#page-top">NewcastleIGEM</a>
            <button class="navbar-toggler navbar-toggler-right" type="button" data-toggle="collapse"
                data-target="#navbarResponsive" aria-controls="navbarResponsive" aria-expanded="false"
                aria-label="Toggle navigation">
                Menu
                <i class="fas fa-bars"></i>
            </button>
            <div class="collapse navbar-collapse" id="navbarResponsive">
                <ul class="navbar-nav text-uppercase ml-auto">
                    <li class="nav-item dropdown">
                        <a class="nav-link" href="../index.html" id="home">Home</a>
                    </li>
                    <li class="nav-item dropdown">
                        <!-- button -->
                        <a class="nav-link dropdown-toggle" id="active" data-toggle="dropdown" href="#">People</a>
                        <!-- dropdown content -->
                        <div class="dropdown-menu">
                            <a class="dropdown-item" href="../team/teampage.html">Team</a>
                            <a class="dropdown-item" href="../collaborations/collaborations.html">Collaborations</a>
                            <a class="dropdown-item" href="../attributions/attributions.html">Attributions</a>
                        </div>
                    </li>
                    <li class="nav-item dropdown">
                        <!-- button -->
                        <a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Project</a>
                        <!-- dropdown content -->
                        <div class="dropdown-menu">
                            <a class="dropdown-item" href="../description/description.html">Description</a>
                            <a class="dropdown-item" href="../design/design.html">Design</a>
                            <a class="dropdown-item" href="../experiments/experiments.html">Experiments</a>
                            <a class="dropdown-item" href="../notebook/notebook.html">Notebook</a>
                            <a class="dropdown-item" href="../results/results.html">Results</a>
                            <a class="dropdown-item" href="../demonstrate/demonstrate.html">Demonstrate</a>
                            <a class="dropdown-item" href="../improve/improve.html">Improve</a>
                        </div>
                    </li>
                    <li class="nav-item dropdown">
                        <!-- button -->
                        <a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Human Practices</a>
                        <!-- dropdown content -->
                        <div class="dropdown-menu">
                            <a class="dropdown-item" href="../human practices/humanpractices.html">Humans Practices</a>
                            <a class="dropdown-item" href="../education & engagement/education.html">Education &
                                Engagement</a>
                        </div>
                    </li>
                    <li class="nav-item dropdown">
                        <!-- button -->
                        <a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Parts</a>
                        <!-- dropdown content -->
                        <div class="dropdown-menu">
                            <a class="dropdown-item" href="../parts overview/partsoverview.html">Parts Overview</a>
                            <a class="dropdown-item" href="../basic parts/basicparts.html">Basic Parts</a>
                            <a class="dropdown-item" href="../composite parts/compositeparts.html">Composite Parts</a>
                            <a class="dropdown-item" href="../parts collection/partscollection.html">Part Collection</a>
                        </div>
                    </li>
                    <li class="nav-item dropdown">
                        <!-- button -->
                        <a class="nav-link dropdown-toggle" data-toggle="dropdown" href="#">Awards</a>
                        <!-- dropdown content -->
                        <div class="dropdown-menu">
                            <a class="dropdown-item" href="../medals/medals.html">Medals</a>
                        </div>
                    </li>

                    <a id="instagram" class="socialmedia d-none d-lg-block"
                        href="https://www.instagram.com/newcastle_igem/?hl=en"><i class="fab fa-instagram"></i></a>
                    <a id="twitter" class="socialmedia d-none d-lg-block" href="https://twitter.com/ncl_igem"><i
                            class="fab fa-twitter"></i></a>
                </ul>
            </div>
        </div>
    </nav>

    <div class="container">


        <section>
            <h1 class="text-center">Project Description</h1>
        </section>


        <section class="secBorder left">
            <hr>
            <p>Parkinson’s UK estimates 145,000 people were diagnosed with Parkinson’s disease in the UK in
                2018 and that 1
                in 37 people will develop PD in their lifetime. Neurological disorders are a leading source of
                disability
                and death worldwide <span class="referenceLink">[ <a href="#ref-1">1</a> ]</span>. The burden of
                neurodegenerative disorders “such as PD” have arisen due to a
                global
                increase in population numbers and life expectancy <span class="referenceLink">[<a href="#ref-2">2</a>,
                    <a href="#ref-3">3</a>]</span> . Current diagnostic procedures rely on the
                identification of motor symptoms related to PD. By the time motor symptoms are distinguishable, over 60%
                of
                all dopamine neurons may have been lost - resulting in significant irreversible neurological damage
                <span class="referenceLink">[ <a href="#ref-4">4</a> ]</span>.
                Early diagnoses of PD patients for non-motor symptoms are limited, but can often be misdiagnosed for
                depression, anxiety, and age-related cognitive decline <span class="referenceLink">[ <a
                        href="#ref-5">5</a> ]</span>.</p>
        </section>

        <section class="secBorder right">
            <hr>
            <p>We are attempting to use a triplet biomarker system to provide indication of that an early
                Parkinson’s
                diagnosis may be required. By engineering three independent bacteria, E. coli (K12), to detect the
                presence
                of specific molecules associated with Parkinson's disease; alpha-synuclein associated transcription
                factor
                GATA2, dermal eicosane (characteristic of seborrheic dermatitis - a skin condition associated with
                suppressed immune systems), and a decrease in the anti-oxidant glutathione. Each biomarker will run
                independently, and only a collective positive result for all three tests will result in a confirmed need
                for
                a diagnosis of Parkinson’s disease. We plan to test experimental controls using pure chemical samples
                from
                suppliers, diluted to mimic concentrations found in both patient blood and serum levels.</p>
        </section>



        <section class="secBorder">
            <hr>
            <div class="row">

                <div class="col-lg-6">
                    <h5>The Eicosane biosensor</h5>

                    <p>In the study involving Milne, the three main volatile organic compounds – hippuric acid,
                        eicosane and
                        octadecanal – were upregulated in Parkinson’s subjects. Eicosane increased significantly in
                        Parkinson’s
                        patients. Although hippuric acid and octadecanal was observed to be higher in PD patients, they
                        did
                        not
                        increase significantly <span class="referenceLink">[ <a href="#ref-2">2</a> ]</span>. As
                        eicosane increased the most significantly, we will use this as
                        the
                        biomarker
                        related to seborrheic dermatitis.</p>
                </div>
                <div class="col-lg-6">
                    <img id="firstimg" src="https://2019.igem.org/wiki/images/4/4b/T--Newcastle--2019%3BEicosane1.jpg"
                        alt="Eicosane">
                </div>

            </div>
            <p>LadA is a long-chain alkane monooxygenase capable of converting eicosane into its
                corresponding primary
                alcohol, 1-eicosanol <span class="referenceLink">[ <a href="#ref-7">7</a> ]</span>. We will use part
                BBa_K398017 from the iGEM registry as our LadA
                equivalent
                to show
                that eicosane can be converted into eicosanol. An alcohol dehydrogenase promoter is incorporated
                in
                the
                biosensor for the detection of eicosanol and RFP will be expressed. As the fluorescence is
                proportional to
                the level of eicosanol present, we would expect a higher fluorescence in PD patients compared to
                a
                control.
            </p>
        </section>



        <section class="secBorder" style="position: relative">
            <hr>
            <h5> The Glutathione biosensor </h5>




            <p>
                <img src="https://2019.igem.org/wiki/images/b/b9/T--Newcastle--2019%3Bglutathionebiosensor1.png"
                    alt="glutathione" class="float-left">
                Glutathione is an antioxidant that protects cells by preventing cellular damage and disruption of
                metabolic
                pathways. This molecule has a strong association with PD as the levels in the brain and blood
                decreases;
                the
                lower the levels of glutathione, the more severe Parkinson’s symptoms <span class="referenceLink">[ <a
                        href="#ref-7">7</a> ]</span>. There are currently no
                methods of
                detecting glutathione as glutathione cannot be detected directly through a transcription factor.
                The
                team
                aims to detect changes in glutathione levels by measuring the induced fluorescence associated
                with
                hydrolysed glutathione product glycine, as well as transcription factors gcvR and gcvA. As PD
                patients
                have
                lower levels of glutathione in the blood than the average person, we would expect an optimised
                system to
                display higher levels of fluorescence in a control patient and lower fluorescence in a PD
                patient.</p>

        </section>


        <section class="secBorder left">
            <hr>
            <h5> Our inspiration </h5>

            <p>“Super Smeller” Joy Milne had a unique ability to distinguish the “smell” of Parkinson’s on her late
                husband.
                Joy described her husband Les as smelling “musky” up-to 10 years prior to his Parkinson’s diagnosis
                <span class="referenceLink">[ <a href="#ref-2">2</a> ]</span>.
                In
                a pilot study conducted at Edinburgh University, a T-shirt sampling smell test of 12 individuals: 6
                participants had diagnosed Parkinson’s disease and 6 were healthy controls. Milne correctly identified
                11/12
                subjects; with misidentification of one control subject. However, the misidentified control was
                diagnosed
                with Parkinson’s disease several months later, indicating Milne was correct on all counts <span
                    class="referenceLink">[ <a href="#ref-8">8</a> ]</span>. The musky
                odour was later linked to seborrheic dermatitis, a common inflammatory skin disorder. The
                over-production of
                sebum characterised by Malassezia growth, this is a non-motor symptom of Parkinson’s due to immune
                deficiency<span class="referenceLink"> [ <a href="#ref-9">9</a> ]</span>.</p>
        </section>


        <section id="references" class="secBorder">
            <hr>
            <h5>References</h5>

            <p>

                <ol>
                    <li id="ref-1">Feigin VL, Abajobir AA, Abate KH, Abd-Allah F, Abdulle AM, Abera SF, et al. Global,
                        regional,
                        and
                        national burden of neurological disorders during 1990–2015: a systematic analysis for the Global
                        Burden
                        of
                        Disease Study 2015. The Lancet Neurology. 2017;16(11):877-97.</li>
                    <li id="ref-2">Trivedi DK, Sinclair E, Xu Y, Sarkar D, Walton-Doyle C, Liscio C, et al. Discovery of
                        volatile
                        biomarkers
                        of Parkinson’s disease from sebum. ACS Central Science. 2019.</li>
                    <li id="ref-3">Dorsey ER, Elbaz A, Nichols E, Abd-Allah F, Abdelalim A, Adsuar JC, et al. Global,
                        regional, and
                        national
                        burden of Parkinson's disease, 1990–2016: a systematic analysis for the global burden of disease
                        study
                        2016.
                        The Lancet Neurology. 2018;17(11):939-53.</li>
                    <li id="ref-4">Pagan FL. Improving outcomes through early diagnosis of Parkinson's disease. American
                        Journal of
                        Managed
                        Care. 2012;18(7):S176.</li>
                    <li id="ref-5">Korczyn AD, Gurevich T. Parkinson's disease: before the motor symptoms and beyond.
                        Journal of
                        the
                        neurological sciences. 2010;289(1-2):2-6.</li>
                    <li id="ref-6">Li L, Liu X, Yang W, Xu F, Wang W, Feng L, et al. Crystal structure of long-chain
                        alkane
                        monooxygenase
                        (LadA) in complex with coenzyme FMN: unveiling the long-chain alkane hydroxylase. Journal of
                        molecular
                        biology. 2008;376(2):453-65.</li>
                    <li id="ref-7"> Mischley LK, Standish LJ, Weiss NS, Padowski JM, Kavanagh TJ, White CC, et al.
                        Glutathione as a
                        biomarker
                        in Parkinson’s disease: Associations with aging and disease severity. Oxidative medicine and
                        cellular
                        longevity. 2016;2016.</li>
                    <li id="ref-8">Morgan J. Joy of super smeller: sebum clues for PD diagnostics. The Lancet Neurology.
                        2016;15(2):138-9.</li>
                    <li id="ref-9">Ravn A-H, Thyssen JP, Egeberg A. Skin disorders in Parkinson’s disease: potential
                        biomarkers and
                        risk
                        factors. Clinical, cosmetic and investigational dermatology. 2017;10:87.</li>
                </ol>


            </p>
        </section>
    </div>






    <!-- Bootstrap Javascript -->
    <script src="https://code.jquery.com/jquery-3.3.1.slim.min.js"
        integrity="sha384-q8i/X+965DzO0rT7abK41JStQIAqVgRVzpbzo5smXKp4YfRvH+8abtTE1Pi6jizo"
        crossorigin="anonymous"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/popper.js/1.14.7/umd/popper.min.js"
        integrity="sha384-UO2eT0CpHqdSJQ6hJty5KVphtPhzWj9WO1clHTMGa3JDZwrnQq4sF86dIHNDz0W1"
        crossorigin="anonymous"></script>
    <script src="https://stackpath.bootstrapcdn.com/bootstrap/4.3.1/js/bootstrap.min.js"
        integrity="sha384-JjSmVgyd0p3pXB1rRibZUAYoIIy6OrQ6VrjIEaFf/nJGzIxFDsf4x0xIM+B07jRM"
        crossorigin="anonymous"></script>


    <!-- Navbar js -->
    <script src="../navbar/navbar.js"></script>

</body>

</html>